CDSCO's New Intelligence Cell to Check Illegal Activity in Pharma Sector
India’s central drug regulator, Central Drugs Standard Control Organisation (CDSCO), has set up a nine-member intelligence cell to track illegal activity in the country’s pharmaceutical sector. This includes gathering information on the medicines and cosmetics imported or exported against the law and investigating complaints related to medicine quality received from overseas regulatory agencies, according to an office order quoted in an Economic Times report.
The intelligence cell will be in charge of collecting and collating information on activities carried out in contravention to the provisions of the Drugs & Cosmetics Act, 1940, stated the order. It will also assist in raids in collaboration with zonal and sub-zonal offices.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Launches Concentrated Anti-Dumping Actions Against Eight Categories of Chinese Chemicals, Covering APIs/Intermediates, Polyurethanes, and Refrigerants
-
Three Major Indian Chemical Investments Target China's PC Exports
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
-
India Imposes Anti-Dumping Duties on Chinese vitamin A Palmitate and Insoluble Sulfur Products
-
Indian Government Increases Excise Duty on Petrol and Diesel
-
India Considers Removing Taxes on U.S. Liquefied Natural Gas to Boost Imports
Recommend Reading
-
Chemicals Take the Hit as China's Markets Thin Out — Wanhua, Juhua Chemical Slide Over 2%
-
Kemira Acquires AquaBlue
-
US Imposes Heavy Duties on Chinese L-Lysine with Combined Rates up to 188%
-
Wanhua USA Reaches $7.75 Million Settlement in MDI/TDI Antitrust Lawsuit
-
South Korea Retires 1.39 Million Tonnes of Ethylene Capacity as Northeast Asia’s Petrochemical Reset Turns Real
-
Business Society’s Market Outlook for MIBK on September 4, 2026: Fluctuating Trend
-
Business Society’s Market Outlook for Dichloromethane on September 4, 2026: Volatile Fluctuations
-
Business Society’s PVC Market Outlook on August 11, 2026: Stable with a Slight Rise
-
Business Society’s PVC Market Outlook on September 4, 2026: Relatively Strong Fluctuations
-
Business Society’s LDPE Market Outlook on August 10, 2026: Volatile with a Slight Bullish Bias
- Hot Searches
- polyurethane china
- where can i buy reta peptide
- proplyne glycol
- active pharmaceutical ingredients bestellen
- pvc prices
- crude glycerine
- methylene blue suppliers
- solvent naphtha suppliers
- ambroxolhydrochloride
- nsi-189 buy online
- retatrutide supplier china
- acrylonitrile butadiene styrene price